scispace - formally typeset
J

Jean-Jacques Body

Researcher at Université libre de Bruxelles

Publications -  397
Citations -  21506

Jean-Jacques Body is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Breast cancer & Zoledronic acid. The author has an hindex of 70, co-authored 384 publications receiving 19608 citations. Previous affiliations of Jean-Jacques Body include The Breast Cancer Research Foundation & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Assessment of dyspnea in advanced cancer patients

TL;DR: No single assessment tool considers all the different components of dyspnea, and the final choice will depend on the purpose of the assessment, taking into account that the provision of quality of life is of paramount importance to patients who have limited time left to them and that the assessment should not therefore detract from the quality oflife by being overlong, complicated or invasive.
Journal ArticleDOI

Calcitonin Deficiency in Primary Hypothyroidism

TL;DR: The process that causes hypothyroidism in patients with autoimmune thyroid disease can also cause marked CT deficiency, and this first demonstration of spontaneous CT deficiency in adults should contribute to the understanding of CT physiology; it also suggests that bone metabolism should be closely monitored during the treatment of primary hypothy thyroid disease.
Journal ArticleDOI

Health Technology Assessment in Osteoporosis

TL;DR: Health technology assessment is increasingly used in the field of osteoporosis and could be very useful to help decision makers efficiently allocate health-care resources and suggest that the recent advances in the prevention and treatment of osteopsorosis may constitute an efficient basis for the allocation of scarce health- Care resources.
Journal ArticleDOI

Human chorionic gonadotropin-like substance in plasma of normal nonpregnant subjects and women with breast cancer.

TL;DR: The plasma concentration of the hCG-like substance is normally very low but dependent on gonadal function in women, and its concentration is much increased in postmenopausal women with breast carcinoma.